345 related articles for article (PubMed ID: 7520928)
1. Evidence for the expression of three different BoLA-class II molecules on the bovine BL-3 cell line: determination of a non-DR non-DQ gene product.
Ababou A; Goyeneche J; Davis WC; Lévy D
J Leukoc Biol; 1994 Aug; 56(2):182-6. PubMed ID: 7520928
[TBL] [Abstract][Full Text] [Related]
2. Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens.
Horejsí V; Nĕmec M; Angelisová P; Kristofová H; Gorga JC; Hilgert I
Tissue Antigens; 1986 Nov; 28(5):288-97. PubMed ID: 2435017
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a monoclonal antibody recognizing a monomorphic determinant of DR antigens.
Schütt C; Horejsi V; Walzel H; Siegl E
Biomed Biochim Acta; 1989; 48(4):359-63. PubMed ID: 2473743
[TBL] [Abstract][Full Text] [Related]
4. The DA6-147 monoclonal antibody raised against the HLA-DR alpha chain identifies a cryptic epitope on the BoLA-DR alpha chain.
Ababou A; Davis WC; Levy D
Vet Res; 1993; 24(5):402-7. PubMed ID: 7505154
[TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to HLA-DP, DQ, and DR determinants: functional effects on the activation and proliferation of normal and EBV-transformed B cells.
Howard DR; Eaves AC; Takei F
Exp Hematol; 1986 Oct; 14(9):887-95. PubMed ID: 2428652
[TBL] [Abstract][Full Text] [Related]
6. Monoclonal antibodies to sheep MHC class II molecules recognize all HLA-D or subsets of HLA-D region products.
Puri NK; de Kretser T; Brandon MR
Hum Immunol; 1987 Nov; 20(3):195-207. PubMed ID: 3501780
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies that distinguish between class II antigens (HLA-DP, DQ, and DR) in 14 haplotypes.
Robbins PA; Evans EL; Ding AH; Warner NL; Brodsky FM
Hum Immunol; 1987 Apr; 18(4):301-13. PubMed ID: 3494718
[TBL] [Abstract][Full Text] [Related]
8. Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.
Sakai K; Takiguchi M; Mori S; Kobori O; Morioka Y; Inoko H; Sekiguchi M; Kano K
J Natl Cancer Inst; 1987 Nov; 79(5):923-32. PubMed ID: 2960847
[TBL] [Abstract][Full Text] [Related]
9. A strategy to determine HLA class II restriction broadly covering the DR, DP, and DQ allelic variants most commonly expressed in the general population.
McKinney DM; Southwood S; Hinz D; Oseroff C; Arlehamn CS; Schulten V; Taplitz R; Broide D; Hanekom WA; Scriba TJ; Wood R; Alam R; Peters B; Sidney J; Sette A
Immunogenetics; 2013 May; 65(5):357-70. PubMed ID: 23392739
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of cell membrane of B-lymphocytes in chronic lymphocytic leukemia. I. Expression of class II antigens (HLA-D)].
Pluta A; Górski A; Nowaczyk M
Pol Arch Med Wewn; 1991 Sep; 86(3):149-53. PubMed ID: 1725558
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
Pesando JM; Graf L
J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
[TBL] [Abstract][Full Text] [Related]
12. NetMHCIIpan-3.0, a common pan-specific MHC class II prediction method including all three human MHC class II isotypes, HLA-DR, HLA-DP and HLA-DQ.
Karosiene E; Rasmussen M; Blicher T; Lund O; Buus S; Nielsen M
Immunogenetics; 2013 Oct; 65(10):711-24. PubMed ID: 23900783
[TBL] [Abstract][Full Text] [Related]
13. Discrimination between major histocompatibility complex class II DQ and DR locus products in cattle.
Dutia BM; MacCarthy-Morrogh L; Glass EJ; Knowles G; Spooner RL; Hopkins J
Anim Genet; 1995 Apr; 26(2):111-4. PubMed ID: 7733491
[TBL] [Abstract][Full Text] [Related]
14. Identification with the monoclonal antibody 26.163 of a determinant shared by the beta chains of the gene products of the HLA-DR, DQ, and DP loci.
Igarashi M; Gebhard DH; Chen YX; Safai B; Evans RL; Ferrone S
Hum Immunol; 1986 Aug; 16(4):347-55. PubMed ID: 2428781
[TBL] [Abstract][Full Text] [Related]
15. mAb KUL/05 identifies a denaturation-resistant determinant shared by class II MHC products DR, DQ and DP.
Giacomini P; Tecce R; Nicotra MR; Cohen BB; Mazzilli MC; Natali PG
J Immunogenet; 1989 Jun; 16(3):203-16. PubMed ID: 2482314
[TBL] [Abstract][Full Text] [Related]
16. HLA class II alleles in juvenile dermatomyositis.
Vavrincová P; Havelka S; Cerna M; Stastny P
J Rheumatol Suppl; 1993 Apr; 37():17-8. PubMed ID: 8501745
[TBL] [Abstract][Full Text] [Related]
17. An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP.
Ono SJ; Bazil V; Sugawara M; Strominger JL
J Exp Med; 1991 Mar; 173(3):629-37. PubMed ID: 1997650
[TBL] [Abstract][Full Text] [Related]
18. The role of tumor-associated antigen in bovine leukemia virus-induced lymphosarcoma.
Aida Y; Nishino Y; Amanuma H; Murakami K; Okada K; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():216-8. PubMed ID: 9209345
[TBL] [Abstract][Full Text] [Related]
19. Detection of HLA-DP serological allodeterminants by the use of radioiodinated DP molecules.
Tanigaki N; Tosi R; Parodi B; Sorrentino R; Ferrara GB; Strominger JL
Eur J Immunol; 1987 Jun; 17(6):743-50. PubMed ID: 2439347
[TBL] [Abstract][Full Text] [Related]
20. Induction of MHC class II molecules HLA-DR, -DP and -DQ and ICAM 1 in human podocytes by gamma-interferon.
Baudeau C; Delarue F; Hé CJ; Nguyen G; Adida C; Peraldi MN; Sraer JD; Rondeau E
Exp Nephrol; 1994; 2(5):306-12. PubMed ID: 7812737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
